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Dietary n−3 polyunsaturated fatty acids (PUFAs) have been reported to exhibit antiarrhyth-
mic properties, and these effects have been attributed to their capability to modulate
ion channels. In the present review, we will focus on the effects of PUFAs on a cardiac
sodium channel (Nav1.5) and two potassium channels involved in cardiac atrial and ventric-
ular repolarization (Kv) (Kv1.5 and Kv11.1). n−3 PUFAs of marine (docosahexaenoic, DHA
and eicosapentaenoic acid, EPA) and plant origin (alpha-linolenic acid, ALA) block Kv1.5 and
Kv11.1 channels at physiological concentrations. Moreover, DHA and EPA decrease the
expression levels of Kv1.5, whereas ALA does not. DHA and EPA also decrease the magni-
tude of the currents elicited by the activation of Nav1.5 and calcium channels.These effects
on sodium and calcium channels should theoretically shorten the cardiac action potential
duration (APD), whereas the blocking actions of n−3 PUFAs on Kv channels would be
expected to produce a lengthening of cardiac action potential. Indeed, the effects of n−3
PUFAs on the cardiac APD and, therefore, on cardiac arrhythmias vary depending on the
method of application, the animal model, and the underlying cardiac pathology.
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INTRODUCTION
Omega-3 (n−3) polyunsaturated fatty acids (PUFAs) are essential
nutrients that must be acquired from the diet and that are required
for normal development and cellular function. n−3 PUFAs are
derived from two sources: (1) ALA (18:3 n−3), which is found
in vegetable oils (such as flaxseed, canola, and soybean oils) and
walnuts, and (2) EPA (20:5 n−3) and DHA (22:6 n−3), which are
found in oily fish, fish oil, and seafood (Figure 1). After the Indus-
trial Revolution, the dramatic increase in the n−6-to-n−3 ratio
in the diets of the populations of Western countries has, at least
in part, contributed to the rise in cardiovascular disease (CVD;
De Caterina et al., 2003; Leaf et al., 2003). Sinclair et al. described
the rarity of CVD in Greenland Eskimos, who consumed a diet
rich in n−3 PUFAs (whale, seal, and fish; Sinclair, 1953, 1956).
Since that time, a large amount of evidence from cellular, ani-
mal studies (Billman et al., 1997, 1999; Leifert et al., 2000), and
from clinical trial outcomes (Burr et al., 1989; GISSI-Prevenzione
Investigators, 1999; Tanaka et al., 2008; Tavazzi et al., 2008) has
suggested that an increased intake of fish oil fatty acids has favor-
able effects on cardiovascular health. Analyses of these trials have
concluded that these beneficial effects mainly occur through the
prevention of sudden cardiac death (SCD), which is often pre-
ceded by ventricular arrhythmias, indicating that n−3 PUFAs are
antiarrhythmic (GISSI-Prevenzione Investigators, 1999; Marchi-
oli et al., 2002). However, not all studies have demonstrated the
cardioprotective effects on CVD of PUFA consumption. Proar-
rhythmic actions have been described for n−3 PUFAs in animal
models during acute regional myocardial ischemia (Coronel et al.,
2007). Moreover, the recent Alpha OMEGA and OMEGA ran-
domized trials, involving patients who had suffered a myocardial
infarction, did not show any improvement in the clinical results
following n−3 PUFAs supplementation (Kromhout et al., 2010;
Rauch et al., 2010), and a deleterious effect due to an increased
risk of cardiac death was reported in men with stable angina
(without myocardial infarction) who were advised to eat fish
(Burr et al., 2003), and in patients with implantable cardioverter
defibrillators (ICDs; Raitt et al., 2005). These differences could
be explained by the fact that a diet rich in fish oil could be pro-
or antiarrhythmic depending on the underlying arrhythmogenic
mechanism.
In any case, the mechanism underlying the anti- or pro-
arrhythmic effect after n−3 supplementation is thought to be
related to the modulation of the cardiac ion channels involved in
the genesis and/or maintenance of cardiac action potentials (APs).
n−3 PUFAs inhibit the fast sodium current (INa), ultrafast activat-
ing delayed outward potassium current (IKur), transient outward
potassium current (I to), rapidly activating delayed rectifying out-
ward potassium current (IKr) L-type calcium inward current (ICa),
and Na+-Ca2+ exchange current (INCX), and enhanced slowly
activating delayed rectifying outward potassium current (IKs) and
inward rectifying potassium current (IK1; Honoré et al., 1994; Xiao
et al., 1995, 1997; Doolan et al., 2002; Jude et al., 2003; Guizy
et al., 2005, 2008; Verkerk et al., 2006; Dujardin et al., 2008).
Because the configuration and duration of the cardiac AP are
highly relevant for arrhythmogenesis, in the present review, we
summarize the acute and chronic effects of n−3 PUFAs on the
INa, IKur, and IKr (Figure 2) and we will relate these effects with
the pro- and antiarrhythmic effects on different animal models
of arrhythmia, as well as to the results observed in the clinical
trials.
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FIGURE 1 | Structure of the main n−3 (EPA, DHA, and ALA), n−6 (AA and LA), monounsaturated (OA), and saturated (SA and PA) PUFAs present in the
human diet.Taken from the free ChemSpider Database (http://www.chemspider.com/).
EFFECTS OF n−3 PUFAs ON SODIUM CHANNELS
The fast inward cardiac sodium current is responsible for the gen-
esis of the AP (phase 0) in most cells of excitable tissues and plays
a pivotal role in impulse conduction. Thus, the ability of agents
to modulate INa may constitute an important factor to prevent,
terminate, or exacerbate cardiac arrhythmias (Echt et al., 1991).
In 1995, it was reported that EPA reduced membrane electri-
cal excitability of heart myocytes, increased the threshold for the
genesis of the cardiac AP and hyperpolarized the resting mem-
brane potential (Kang et al., 1995). As it was expected, when the
effects of EPA were studied on the fast sodium current in isolated
neonatal rat cardiac myocytes (Xiao et al., 1995) or in the current
generated after activation of cloned human Nav1.5 expressed in a
mammalian cell line (Xiao et al., 1998), an inhibition of the INa
occurred. These effects on sodium channels were concentration-,
time-, and voltage-dependent with an IC50 of 4.8 and 0.5µM
respectively. These IC50 values are within the n−3 PUFAs phys-
iological plasma range in the human being (Burtis et al., 1999).
EPA shifted the inactivation curve toward more negative poten-
tials by ∼20 mV whereas the activation kinetics of the channel
was unaffected. EPA slightly hyperpolarized the resting membrane
potential (likely due to an enhancement of IK1) and made more
positive the threshold for the activation of Nav1.5 channel. In
addition, the transition from the rested to the inactivated state
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FIGURE 2 | Cardiac AP, ionic currents involved in its genesis
and maintenance, and the effects of n−3 PUFAs on each
current under acute and chronic conditions. ↑, Increase; ↓,
decrease; or ∼, no changes in the current amplitude. *Studied in
human atria. ?, Not tested.With permission from Ravens and
Cerbai (2008).
was markedly accelerated in the presence of EPA but the recovery
from inactivation was only slightly prolonged (Xiao et al., 1998;
Dujardin et al., 2008). This effect could account for the greater
relative refractory period-action potential duration (APD) ratio.
Other n−3 (DHA and ALA),n−6 PUFAs (AA), and monounsatu-
rated fatty acid (oleic acid, OA) reduced INa being the n−3 PUFAs
the more potent ones.
In adult rat cardiomyocytes, sodium current was also inhib-
ited by EPA, DHA, and ALA, DHA being the most potent n−3
PUFA blocking sodium channels (IC50 of 6µM), followed by
EPA (IC50 of 16µM) and ALA (IC50 of 27µM). Similarly to
that observed in INa recorded in neonatal cardiomyocytes; DHA,
EPA, and ALA shifted the voltage dependence of inactivation
toward more negative potentials (∼20–23 mV). However, and in
contrast to the effects on the sodium channels of neonatal car-
diomyocytes, these three PUFAs shifted the voltage dependence
of activation toward more positive potentials (∼8–12 mV; Leifert
et al., 1999). In contrast with the acute effects, peak INa was
unaffected by incorporated n−3 PUFAs in ventricular myocytes
isolated from pigs and rats that were fed a diet rich in fish oil
(Leifert et al., 2000; Verkerk et al., 2006). In both studies volt-
age dependence of activation remained unaltered, whereas a shift
(<8 mV) in the inactivation toward more negative potentials was
observed.
It is not clear how PUFAs modulate the activity of ion chan-
nels, if they modify the current through indirect effects on the lipid
bilayer or if they directly interact with the channel protein. The
dominant view is that n−3 PUFAs directly interact with the pro-
tein of the ion channel. A very useful technique used to establish an
interacting site is to introduce single directed point mutations in
the wild type protein and to determine whether the substitution
modifies the expected action of the ligand. Due to the striking
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similarities between the n−3 PUFAs effects and those induced
by local anesthetics, the effects of n−3 PUFAs were analyzed on
Nav1.5 channels carrying point amino acid mutations that have
been shown to modify the action of local anesthetics (Xiao et al.,
2001). Interestingly, the substitution of an asparagine by a lysine at
position 406 (N406K) at the segment 6 of the domain 1 of Nav1.5
channel significantly reduced the potency of EPA to inhibit INa,
mimicking bupivacaine effects and suggesting a direct interac-
tion with this protein (Nau et al., 2000; Xiao et al., 2001). Also,
the effects of n−3 PUFAs on the sodium current generated by
the activation of Nav1.5 channels expressed in HEK293 cells were
modified by the cotransfection with accessory β subunits (Xiao
et al., 2000).
On the basis of these results, sodium channel blockade pro-
duced by n−3 PUFAs is responsible, at least in part, for the antiar-
rhythmic or proarrhythmic effects observed in clinical trials. In the
clinics, class I antiarrhythmic drugs, such as flecainide, are useful
in the treatment of atrial fibrillation (Fuster et al., 2011). Thus, we
can speculate that the sodium current inhibition properties of n−3
PUFAs can account for the beneficial effects observed in clinical
trials focused on atrial fibrillation (Calo et al., 2005). Conversely,
blockade of the cardiac sodium channel can be deleterious under
certain pathological conditions in which arrhythmias are based
on reentrant activity, such as during acute myocardial ischemia.
Sodium channel blockade by acute administration of n−3 PUFAs,
likely facilitates reentry by slowing conduction velocity and incor-
porated n−3 PUFAs shorten APD and effective refractory period
(ERP), because these conditions favor a reentrant circuit to arise.
In fact, an increase in the risk of cardiac events has been reported in
patients with acute ischemia (e.g., angina pectoris) and in patients
with histories of sustained ventricular tachycardia or ventricular
fibrillation, as well as arrhythmias triggered by reentry (Burr et al.,
2003; Brouwer et al., 2009).
EFFECTS OF n−3 PUFAs ON REPOLARIZING CURRENTS
The ultrarapid activated outward potassium current is the native
counterpart to Kv1.5 channels in human atria and contribute to
the repolarization process of the atrial AP (Fedida et al., 1993; Sny-
ders et al., 1993). Since the early nineties, it is known that Kv1.5
current is inhibited by the acute exposition to n−3 (DHA), and
n−6 PUFAs (AA), but not by monounsaturated (OA) and satu-
rated fatty acids (palmitic acid, PA and stearic acid, SA) in stably
expressing Kv1.5 mammalian cells (Honoré et al., 1994). The inhi-
bition was time- and concentration-dependent and occurred at
physiological concentrations (IC50 for AA and DHA∼20–30µM)
only when these PUFAs were applied from the external side of the
membrane. Both n−6 and n−3 fatty acid shifted the activation
curve toward more negative potentials ∼16 mV and accelerated
the activation process. All these results are indicative of an open
channel mechanism of block. The same characteristic block was
induced by DHA and AA on the IKur current in mouse neonatal
cardiomyocytes, in rat embryonic ventricular cells (Honoré et al.,
1994) and, more interestingly, in human atrial myocytes (IC50 for
EPA and DHA 17.5 and 4.3µM, respectively; Li et al., 2009).
Guizy et al. (2008) compared acute versus chronic effects of the
plant derived n−3 PUFA ALA on the inhibition of Kv1.5 channels.
The acute ALA blocking properties resembles to those previously
described by Honoré et al. (1994) for DHA and AA. However, in
the case of ALA, the Kv1.5 inhibition was also voltage-dependent.
The chronic effects on the channel function and on its protein
expression levels were assessed by incubating the cells with ALA
10µM for 24 and 48 h. The effects of ALA on the Kv1.5 current
were similar to those obtained when the cells were acutely exposed
to ALA. EPA and DHA, but not ALA, reduced the steady-state
levels of Kv1.5 protein in a concentration-dependent manner at
concentrations higher than 30µM. However, it has also described
that chronic treatment with EPA at low concentrations (∼1µM)
stabilizes Kv1.5 channel protein in the endoplasmic reticulum and
Golgi apparatus thereby enhancing the Kv1.5 channel current on
the cell membrane (Koshida et al., 2009).
As mentioned above, Kv1.5 inhibition was observed when they
were added to the external side of the membrane. This fact strongly
suggests an interaction between n−3 PUFAs and ion channel,
unlike the non-specific lipid-protein interactions proposed for
marine n−3 PUFAs (Leaf and Xiao, 2001). This hypothesis was
tested by measuring changes in the fluorescence anisotropy of the
lipophilic dye PA-DPH on the membrane of Ltk− cells in the
presence of ALA or DHA. The PA-DPH molecule has an anion
polar head and a lipid hydrocarbon chain that resembles mem-
brane lipids. It is incorporated and anchored into the bilayer of
the plasmalemma and its motion reflects the wobbling of its lipidic
components. It was found that DHA but not ALA, modifies the
PA-DPH motion in the Ltk− cell membrane. From these experi-
ments it was concluded that the apparent viscosity and the order
of the membrane rather than the mobility of the bilayer compo-
nents are not affected by ALA, but increased in cells incubated
with DHA (Leifert et al., 1999; Guizy et al., 2008). These results
do not permit us to exclude an effect of DHA on the biophysics of
the lipid bilayer, besides its direct effects on ion channels. In fact,
it has also been reported that n−3 PUFAs are able to change the
composition of membrane microdomains (Basiouni et al., 2012;
Turk and Chapkin, 2012).
The ultra rapid activating delayed rectifier potassium current
IKur, together with I to, repolarizes the cardiomyocyte membrane
in human atria during the AP (Wang et al., 1993) but does not play
a role in the ventricle even though its mRNA and protein are also
present in that tissue (Mays et al., 1995). Thus, inhibition of IKur
prolongs atrial but not ventricular APD and refractoriness. This
finding indicates that IKur blockers can be useful in the treatment
of supraventricular arrhythmias such as AF without the risk of
ventricular pro-arrhythmia (Tamargo et al., 2004). Some of the
cardioprotective effects attributed to n−3 PUFAs may be medi-
ated by the inhibition of Kv1.5 current. This could be particularly
relevant on the treatment of AF. This arrhythmia is associated with
rapid shortening of APD and ERP. In fact, recent epidemiological
studies points out an important role of n−3 PUFAs in the pre-
vention of AF after coronary by-pass surgery (Calo et al., 2005;
Mariscalco et al., 2010).
While atrial repolarization is mostly carried out by I to and IKur,
ventricular repolarization is developed by the slowly activating
delayed rectifier (IKs) and the rapidly activating delayed rectifier
(IKr) currents. The IKr is the native counterpart of Kv11.1 channels
present in the human myocardium (Sanguinetti and Jurkiewicz,
1991; Sanguinetti et al., 1995) and its activity determines the
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duration of the QT interval of the electrocardiogram (ECG) and
therefore the refractory period (Li et al., 1996).
In 2002 it was demonstrated, for the first time, the inhibitory
effects of DHA on IK current (composed by IKs and IKr) in ferret
myocytes. The extracellular application of DHA (10µM) inhib-
ited IK on atrial and ventricular ferret myocytes with an IC50 of
∼20µM. Kv11.1 blockade was concentration- but not voltage-
dependent. Other PUFAs like the n−3 ALA and the n−6 linoleic
acid also decreases the IK magnitude whereas monounsaturated
(OA) and saturated fatty acids (SA) did not (Xiao et al., 2002).
The same n−3 PUFA concentration (10µM) was tested in
another work to characterize the effects of DHA and AA on Kv11.1
human cloned channels (Guizy et al., 2005). Both, AA and DHA
reduced the Kv11.1 current at the end of long depolarizing pulses
and, to a greater extent, at the peak of the deactivation tail cur-
rent, DHA being more potent. Also, Kv11.1 block was voltage-,
time-, and use-dependent. AA and DHA: (1) shifted the activa-
tion curve toward more negative membrane potentials (−5 and
−11 mV, respectively) and shifted the inactivation curve toward
more positive potentials (∼12 mV); (2) accelerated the activa-
tion and the deactivation kinetics; (3) at high rate frequencies,
the Kv11.1 peak current was exponentially reduced; and (4) did
not modify the onset, the inactivation kinetics nor the recovery
process. All these results suggest that AA and DHA preferentially
bind to the open state of the channel (Guizy et al., 2005).
The effects of incorporated n−3 PUFAs were also evaluated
on pig ventricular myocytes fed with a diet rich in n−3 PUFAs
for 8 weeks. In this study, no changes on the amplitude and the
properties of IKr were noticed, thus suggesting different effects of
n−3 PUFAs after acute exposition than after feeding animals (i.e.,
chronic conditions; Verkerk et al., 2006).
n−3 PUFAs, like most antiarrhythmic drugs, modulate
sodium, potassium, and calcium channels, as well as α- and β-
adrenoceptors (Honoré et al., 1994; Xiao et al., 1995, 1997; Hon-
deghem et al., 2001; Jude et al., 2003; Guizy et al., 2005). EPA and
DHA block sodium, calcium, and potassium currents with the
exception of IKs and IK1 (Xiao et al., 1995, 1997; Doolan et al.,
2002; Verkerk et al., 2006). Since n−3 PUFAs inhibit INa, ICa,
and enhance IKs (effects that would shorten the cardiac action
potential), but also inhibit I to, IKur, and IKr (that should produce
a lengthening of the APD), the result should be a modest effect
on the time of repolarization. Besides these effects on the APD,
it should be stated that its inhibitory effects on sodium, calcium,
and several potassium channels (Kv4, and Kv11.1 channels) would
result in a lengthening of the refractory period and a decrease of
cardiac excitability, thus contributing to its antiarrhythmic effects.
The clinical consequences of the effects produced by n−3
PUFAs on Kv11.1 channels are likely dependent on the under-
lying pathology; but we cannot state any conclusion from the data
available in the literature.
EFFECTS OF n−3 PUFAs ON ARRHYTHMIAS ANIMAL
MODELS
In addition to the studies concerning the role of n−3 PUFAs
on ion channels, several cellular, and animal models of induced
arrhythmia have been created to better understand the mechanism
by which n−3 PUFAs protect or exacerbate certain arrhythmias
(Rosen et al., 1991; Members of the Sicilian Gambit, 2001). Tra-
ditional antiarrhythmic drug trials have yielded disappointing
results, probably due to the inclusion of heterogeneous patient
populations with different arrhythmogenic substrate. This led to
the international cardiology community to focus their interest on
the design of new rational approaches to study the effects of antiar-
rhythmic drugs based on mechanism- and disease-specific fashion.
So, during the last years, the pro- or antiarrhythmic effects of n−3
PUFAs have been studied on different animal models with dis-
tinct underlying mechanisms of arrhythmia (triggered activity or
reentry).
ANIMAL MODELS BASED ON ARRHYTHMIAS PRODUCED BY
TRIGGERED ACTIVITY
The effects of EPA and DHA upon APD, triangulation, reverse
use dependence, instability and dispersion (TRIaD) were stud-
ied in female rabbit fed with food enriched with n−3 PUFA
(Dujardin et al., 2008). In this study, n−3 PUFAs significantly
prolonged APD and ERP without triangulation. This apparent
discrepancy with another studies (Verkerk et al., 2006; Den Ruijter
et al., 2010) can be related to the fact that this study was per-
formed in female rabbit hearts, whose repolarization is known to
be slower and is modulated in a different manner (Gaborit et al.,
2010; Lowe et al., 2012). This prolongation of APD resulted in
a significant prolongation of the ERP. At baseline, n−3 PUFAs
pre-treatment had no effects on TRIaD and on ectopic activ-
ity compared with control hearts. By exposing the rabbit heart
to increasing dofetilide concentrations (1–100 nM) torsades de
pointes (TdP, polymorphic ventricular arrhythmia due to trig-
gered activity) was induced. It was studied whether the n−3
PUFA pre-treatment could prevent the proarrhythmic actions of
dofetilide by decreasing TRIaD, and by suppressing the appearance
of TdP. In control hearts, dofetilide-induced TdP in five of the six
rabbit hearts, but none in the hearts from the n−3 PUFAs group.
Hence, dofetilide-induced TRIaD was attenuated by pre-treatment
with dietary supplements of n−3 PUFAs (Dujardin et al., 2008).
Thus, a diet rich in n−3 PUFAs reduce the incidence of early after-
depolarizations (EADs) that could be also benefit in the treatment
of long QT syndrome and other arrhythmias developed by trig-
gered activity (e.g., EADs; Den Ruijter et al., 2006; Dujardin et al.,
2008).
It has been described the beneficial effects of n−3 PUFAs in
arrhythmias associated to heart failure. These beneficial effects
have been reported when n−3 PUFAs are administrated acutely
or as a diet supplementation. The acute administration of fish
oil in cardiac myocytes from rabbits with volume- and pressure-
overload-induced heart failure and of patients with end-stage
heart failure inhibited triggered arrhythmias by lowering intracel-
lular calcium and decreasing the response to noradrenaline (Den
Ruijter et al., 2008). In this study, it is also reported a shortening
of the cardiac APD induced by n−3 PUFAs. Recently, in the same
animal model the authors demonstrate that supplementation of
the diet with n−3 PUFAs reduces hypertrophy. They also describe
a shortening of the cardiac action potential due to an increase
in the magnitude of I to and IK1, a decrease of the Ca2+ tran-
sients and of the incidence of delayed afterdepolarizations. Thus,
n−3 PUFAs prevented electric remodeling associated with heart
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failure, leading to a reduced susceptibility of arrhythmias (Den
Ruijter et al., 2012).
ANIMAL MODELS BASED ON REENTRANT ARRHYTHMIAS
Dietary n−3 fatty acids decreased the incidence of fatal heart dis-
ease relative to placebo (GISSI-Prevenzione Investigators, 1999).
However, n−3 PUFAs tended to increase the risk of SCD in
patients with angina pectoris (without myocardial infarction; Burr
et al., 2003). Coronel et al. (2007) demonstrated in a pig ischemia
model (produced by occluding the left anterior descending artery)
that the supplementation of the diet with n−3 PUFAs during
8 weeks, did not modified ERP or the conduction velocity (nei-
ther longitudinal or transversal), although increased the incidence
of arrhythmias. This study reports that those animals fed with
n−3 PUFAs enriched diet show a reduced excitability, likely due
to their effects on sodium channels, the main determinant of the
substrate of ischemia-induced reentrant arrhythmias.
NEW INSIGHTS OF THE BENEFICIAL PUFAs PROPERTIES:
PUFAs METABOLITES EFFECTS
In addition, genetic, pharmacologic, and biochemical studies are
providing increasing mechanistically relevant explanations for the
salutatory actions of EPA and DHA. n−3 and n−6 PUFAs are
metabolized to lipoxins, resolvins, maresins (Serhan et al., 2008;
Bannenberg and Serhan, 2010). These EPA- and DHA-derived
lipid mediators (collectively termed Specific Pro-resolving Medi-
ators, SPMs) are active, as anti-inflammatory agents, at very low
concentrations (picomolar to nanomolar range), and are degraded
locally by specific inactivating enzymes, characteristic for the
bioactivity of autacoids. These SPMs can also slow the progression
of diabetic onset, CVD, and aging-associated pathologies through
the regulation of innate and adaptive immune responses. It has
been described that lipoxins modulate CRAC channels after bind-
ing to the lipoxin receptor (Li et al., 2008). The effects of SPMs
in the progression of several CVDs, involving inflammation (i.e.,
heart failure, diabetes, coronary heart disease) can be associated
to the beneficial observed effects with n−3 PUFAs in the clinical
trials. However, the cardiac electrophysiological effects of these
SPMs are unknown at the present time. Thus, further studies
focused on the analysis of their effects on cardiac ion channels
and arrhythmias are necessary to better understanding the pro- or
antiarrhythmic effects of n−3 PUFAs.
CONCLUDING REMARKS
n−3 PUFAs have diverse effects (increasing and decreasing) on
cardiac ion currents. These differences appeared to depend on
whether the n−3 PUFAs were applied to the cells or incorpo-
rated in the membranes modifying its composition and, thus, the
effects on cell signaling and, therefore, in ion channel function.
However, we cannot rule out PUFAs direct effects on ion chan-
nels, since once incorporated, n−3 PUFAs can also be released
and there will arise an equilibrium between incorporated and
circulating. n−3 PUFAs modulate cardiac ion currents, leading
to a shortening of the cardiac APD. This effect can be beneficial
or harmful, depending on the underlying pathology. Thus, dur-
ing acute ischemia, in which the duration of the cardiac APD
is already shortened (Behrens et al., 1997), a further decrease
should be proarrhythmic. However, the APD shortening should
be beneficial in preventing those arrhythmias caused by triggered
activity. These differences can account, at least partially, with dis-
crepancies observed in the clinical and epidemiological studies.
Future studies analyzing the electrophysiological effects on car-
diac ion channels and different models of arrhythmia of the n−3
metabolites are needed to better understanding the action of n−3
PUFAs.
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